Full Service CROs in 2025: Trends, Benefits, and What Sponsors Need to Know | Cromos Pharma
Full Service CRO: Benefits, Costs, and How to Choose the Right Partner Clinical trials are not just complex — they are high-risk, time-sensitive investments where delays can cost millions. Choosing the right CRO model is no longer an operational decision, but a strategic one. For many sponsors, the question is not whether to outsource, but whether a full service CRO is the right partner to deliver speed, Read more
The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter | Cromos Pharma
The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter Why clinical trials collect too many endpoints — and how endpoint bloat obscures study goals instead of improving drug development insights. Read more
Five trends from the ASCO Annual Meeting 2026 | Cromos Pharma
ASCO 2026: Five Trends That Caught My Attention By Vlad Bogin, MD, FACP  CEO, Cromos Pharma  ASCO 2026 delivered thousands of abstracts and countless data points. Beyond individual studies, several broader trends stood out to me as particularly important for the future of oncology and clinical development. Precision Oncology Is Becoming More Precise The industry is moving beyond identifying who should receive a treatment and toward determining who may Read more
Clinical Research Focus. 53rd Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of May 2026. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us